|
1
|
Jankowsky JL and Patterson PH: The role of
cytokines and growth factors in seizures and their sequelae. Prog
Neurobiol. 63:125–149. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jankowsky JL and Patterson TA:
Differential regulation of cytokine expression following
pilocarpine-induced seizure. Exp Neurol. 159:333–346. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maroso M, Balosso S, Ravizza T, et al:
Toll-like receptor 4 and high-mobility group box-1 are involved in
ictogenesis and can be targeted to reduce seizures. Nat Med.
16:413–419. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Y and Fuller GM: Phosphorylation and
internalization of gp130 occur after IL-6 activation of Jak2 kinase
in hepatocytes. Mol Biol Cell. 5:819–828. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heinrich PC, Behrmann I, Müller-Newen G,
Schaper F and Graeve L: Interleukin-6-type cytokine signalling
through the gp130/Jak/STAT pathway. Biochem J. 334:297–314.
1998.PubMed/NCBI
|
|
6
|
Funk JA, Gohlke J, Kraft AD, McPherson CA,
Collins JB and Jean HG: Voluntary exercise protects hippocampal
neurons from trimethyltin injury: possible role of interleukin-6 to
modulate tumor necrosis factor receptor-mediated neurotoxicity.
Brain Behav Immun. 25:1063–1077. 2011. View Article : Google Scholar
|
|
7
|
Liu Z, Qiu YH, Li B, Ma SH and Peng YP:
Neuroprotection of interleukin-6 against NMDA-induced apoptosis and
its signal-transduction mechanisms. Neurotox Res. 19:484–495. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thier M, März P, Otten U, Weis J and
Rose-John S: Interleukin-6 (IL-6) and its soluble receptor support
survival of sensory neurons. J Neurosci Res. 55:411–422. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sterneck E, Kaplan DR and Johnson PF:
Interleukin-6 induces expression of peripherin and cooperates with
Trk receptor signaling to promote neuronal differentiation in PC12
cells. J Neurochem. 67:1365–1374. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akaneya Y, Takahashi M and Hatanaka H:
Interleukin-1 beta enhances survival and interleukin-6 protects
against MPP+ neurotoxicity in cultures of fetal rat dopaminergic
neurons. Exp Neurol. 136:44–52. 1995.PubMed/NCBI
|
|
11
|
Toulmond S, Vige X, Fage D and Benavides
J: Local infusion of interleukin-6 attenuates the neurotoxic
effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett.
144:49–52. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
März P, Heese K, Dimitriades-Schmutz B,
Rose-John S and Otten U: Role of interleukin-6 and soluble IL-6
receptor in region-specific induction of astrocytic differentiation
and neurotrophin expression. Glia. 26:191–200. 1999.PubMed/NCBI
|
|
13
|
Tancredi V, D’Antuono M, Cafè C, et al:
The inhibitory effects of interleukin-6 on synaptic plasticity in
the rat hippocampus are associated with an inhibition of
mitogen-activated protein kinase ERK. J Neurochem. 75:634–643.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu Z, Parsons KL and Gruol DL:
Interleukin-6 selectively enhances the intracellular calcium
response to NMDA in developing CNS neurons. J Neurosci.
15:6688–6699. 1995.PubMed/NCBI
|
|
15
|
Quarta S, Vogl C, Constantin CE, Üçeyler
N, Sommer C and Kress M: Genetic evidence for an essential role of
neuronally expressed IL-6 signal transducer gp130 in the induction
and maintenance of experimentally induced mechanical
hypersensitivity in vivo and in vitro. Mol Pain. 7:732011.
View Article : Google Scholar
|
|
16
|
Lee RH, Mills EA, Schwartz N, et al:
Neurodevelopmental effects of chronic exposure to elevated levels
of pro-inflammatory cytokines in a developing visual system. Neural
Dev. 5:22010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Burton MD, Sparkman NL and Johnson RW:
Inhibition of interleukin-6 trans-signaling in the brain
facilitates recovery from lipopolysaccharide-induced sickness
behavior. J Neuroinflammation. 8:542011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Munster BC, Aronica E, Zwinderman AH,
Eikelenboom P, Cunningham C and Rooij SE: Neuroinflammation in
delirium: a postmortem case-control study. Rejuvenation Res.
14:615–622. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jankord R, Zhang R, Flak JN, Solomon MB,
Albertz J and Herman JP: Stress activation of IL-6 neurons in the
hypothalamus. Am J Physiol Regul Integr Comp Physiol.
299:R343–R351. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei H, Zou H, Sheikh AM, et al: IL-6 is
increased in the cerebellum of autistic brain and alters neural
cell adhesion, migration and synaptic formation. J
Neuroinflammation. 8:522011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang X, Burstein R and Levy D: Local
action of the proinflammatory cytokines IL-1β and IL-6 on
intracranial meningeal nociceptors. Cephalalgia. 32:66–72.
2012.
|
|
22
|
D’Arcangelo G, Tancredi V, Onofri F,
D’Antuono M, Giovedì S and Benfenati F: Interleukin-6 inhibits
neurotransmitter release and the spread of excitation in the rat
cerebral cortex. Eur J Neurosci. 12:1241–52. 2000.PubMed/NCBI
|
|
23
|
Terada S, Tsujimoto T, Takei Y, et al:
Inhibitory synaptic transmission in mice lacking synapsin I.
Neurosci Res. 28(Suppl 1): S571997. View Article : Google Scholar
|
|
24
|
Steffensen SC, Campbell IL and Henriksen
SJ: Site-specific hippocampal pathophysiology due to cerebral
overexpression of interleukin-6 in transgenic mice. Brain Res.
652:149–153. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kirkman NJ, Libbey JE, Wilcox KS, White HS
and Fujinami RS: Innate but not adaptive immune responses
contribute to behavioral seizures following viral infection.
Epilepsia. 51:454–464. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Libbey JE, Kennett NJ, Wilcox KS, White HS
and Fujinami RS: Interleukin-6, produced by resident cells of the
central nervous system and infiltrating cells, contributes to the
development of seizures following viral infection. J Virol.
85:6913–6922. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Libbey JE, Kennett NJ, Wilcox KS, White HS
and Fujinami RS: Once initiated, viral encephalitis-induced
seizures are consistent no matter the treatment or lack of
interleukin-6. J Neurovirol. 17:496–499. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fukuda M, Morimoto T, Suzuki Y, Shinonaga
C and Ishida Y: Interleukin-6 attenuates hyperthermia- induced
seizures in developing rats. Brain Dev. 29:644–648. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lehtimäki KA, Peltola J, Koskikallio E,
Keränen T and Honkaniemi J: Expression of cytokines and cytokine
receptors in the rat brain after kainic acid-induced seizures.
Brain Res Mol Brain Res. 110:253–260. 2003.PubMed/NCBI
|
|
30
|
Kalueff AV, Lehtimaki KA, Ylinen A,
Honkaniemi J and Peltola J: Intranasal administration of human IL-6
increases the severity of chemically induced seizures in rats.
Neurosci Lett. 365:106–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peltola J, Hurme M, Miettinen A and
Keränen T: Elevated levels of interleukin-6 may occur in
cerebrospinal fluid from patients with recent epileptic seizures.
Epilepsy Res. 31:129–133. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lehtimäki KA, Keränen T, Palmio J, et al:
Increased plasma levels of cytokines after seizures in
localization-related epilepsy. Acta Neurol Scand. 116:226–230.
2007.PubMed/NCBI
|
|
33
|
Fukumoto Y, Okumura A, Hayakawa F, et al:
Serum levels of cytokines and EEG findings in children with
influenza associated with mild neurological complications. Brain
Dev. 29:425–430. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ben-Menachem E, Sander JW, Stefan H,
Schwalen S and Schauble B: Topiramate monotherapy in the treatment
of newly or recently diagnosed epilepsy. Clin Ther. 30:1180–1195.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Edmonds HL Jr, Jiang YD, Zhang PY and
Shank R: Topiramate as a neuroprotectant in a rat model of global
ischemia-induced neurodegeneration. Life Sci. 69:2265–2277. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Castillo CG, Mendoza S, Freed WJ and
Giordano M: Intranigral transplants of immortalized GABAergic cells
decrease the expression of kainic acid-induced seizures in the rat.
Behav Brain Res. 171:109–115. 2006. View Article : Google Scholar
|
|
37
|
Gadient RA and Otten UH: Interleukin-6
(IL-6) - a molecule with both beneficial and destuctive potentials.
Prog Neurobiol. 52:379–390. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pitkänen A, Savander V and LeDoux JE:
Organization of intra-amygdaloid circuitries in the rat: an
emerging framework for understanding functions of the amygdala.
Trends Neurosci. 20:517–523. 1997.PubMed/NCBI
|
|
39
|
Jankowsky JL, Derrick BE and Patterson PH:
Cytokine responses to LTP induction in the rat hippocampus: a
comparison of in vitro and in vivo techniques. Learn Mem.
7:400–412. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ali C, Nicole O, Docagne F, et al:
Ischemia-induced interleukin-6 as a potential endogenous
neuroprotective cytokine against NMDA receptor-mediated
excitotoxicity in the brain. J Cereb Blood Flow Metab. 20:956–966.
2000. View Article : Google Scholar
|
|
41
|
Calkavur S, Akisu M, Olukman O, et al:
Genetic factors that influence short-term neurodevelopmental
outcome in term hypoxic-ischaemic encephalopathic neonates. J Int
Med Res. 39:1744–1756. 2011. View Article : Google Scholar
|
|
42
|
Pitkänen A: Efficacy of current
antiepileptics to prevent neurodegeneration in epilepsy models.
Epilepsy Res. 50:141–160. 2002.PubMed/NCBI
|
